Human T cell responses against the major cysteine proteinase (cruzipain) of Trypanosoma cruzi: role of the multifunctional alpha 2-macroglobulin receptor in antigen presentation by monocytes.
Chagas' disease patients (CDP) develop both humoral and cellular immune responses against the major cysteine proteinase (cruzipain) from Trypanosoma cruzi. Here we demonstrate that complexes formed by cruzipain and alpha 2-macroglobulin (alpha 2M) are efficiently internalized by human monocytes, and that this process results in enhanced presentation of cruzipain peptides to CD4+ T cells from CDP. Purified or serum alpha 2M binds to polymorphic cruzipains, but only a fraction of the proteinases become covalently linked. Once bound to alpha 2M, fluorescein-labeled cruzipain (FITC-cruzipain) or [125I]cruzipain were more efficiently internalized by normal peripheral blood mononuclear cells (PBMC) or monocytes; this effect was abolished by (I) pre-treating the cells with receptor-associated protein (rRAP), a known antagonist the of alpha 2M receptor (alpha 2MR/LRP), and (II) inactivating [125I]cruzipain's active site prior to the reaction with alpha 2M, indicating that the exposure of receptor binding sites on alpha 2M complexes required bait region cleavage. We then sought to determine if the alpha 2MR/LRP-dependent uptake of alpha 2M:cruzipain by monocytes resulted in increased CD4+ T cell responses of PBMC-CDP (n = 13). These effects were only revealed after depletion of CD19+ B lymphocytes from PBMC-CDP; the threshold of T cell stimulation was far lower in cultures stimulated with alpha 2M:cruzipain, as compared to antigen alone. Myocardial specimens from CDP with chronic myocardiopathy (three necropsies) were analyzed by immunohistochemistry with mAb anti-cruzipain or anti-alpha 2MR/LRP (CD81+). Extracellular depots of cruzipain were localized amidst inflammatory mononuclear infiltrates, part of which contained CD91+ macrophage-like cells. Ongoing studies should clarify if T. cruzi cysteinyl proteinases play a role in the pathogenesis of Chagas' heart disease.
Morrot
A
A
Instituto de Biofisica Carlos Chagas Filho-UFRJ, Laboratório de Imunologia Molecular, Rio de Janeiro, Brazil.
Strickland
D K
DK
Higuchi
M de L
Mde L
Reis
M
M
Pedrosa
R
R
Scharfstein
J
J
D000818:Animals; D017951:Antigen Presentation; D000953:Antigens, Protozoan / Q000276:immunology*; D003546:Cysteine Endopeptidases / Q000276:immunology* / Q000378:metabolism; D006023:Glycoproteins / Q000276:immunology; D006801:Humans; D026503:Low Density Lipoprotein Receptor-Related Protein-1; D008213:Lymphocyte Activation; D009000:Monocytes / Q000201:enzymology* / Q000276:immunology; D009205:Myocarditis / Q000201:enzymology / Q000276:immunology / Q000473:pathology; D015800:Protozoan Proteins; D011971:Receptors, Immunologic / Q000276:immunology / Q000502:physiology*; D013601:T-Lymphocytes / Q000276:immunology*; D014349:Trypanosoma cruzi / Q000201:enzymology* / Q000276:immunology*; D000511:alpha-Macroglobulins / Q000378:metabolism
D000953:Antigens, Protozoan; D006023:Glycoproteins; D026503:Low Density Lipoprotein Receptor-Related Protein-1; D015800:Protozoan Proteins; D011971:Receptors, Immunologic; D000511:alpha-Macroglobulins; D003546:Cysteine Endopeptidases; C063214:cruzipain